文献速递牙体牙髓病

二甲双胍通过激活AMPK信号促进牙髓细胞向成牙本质细胞分化

Metformin Enhances the Differentiation of Dental Pulp Cells into Odontoblasts by Activating AMPK Signaling.
PubMed 文献 · J Endod · 2018-01-04

本研究探讨二甲双胍对人牙髓细胞(DPCs)增殖和分化的影响。结果显示二甲双胍呈剂量依赖性激活AMPK通路,促进碱性磷酸酶活性、矿化结节形成及成牙本质标志物表达,而AMPK抑制剂Compound C可逆转上述效应,提示二甲双胍以AMPK依赖方式诱导DPCs成牙本质分化。

要点

  • 二甲双胍在≤50 μmol/L浓度下不影响DPCs增殖,细胞活力>90%。
  • 二甲双胍剂量依赖性激活AMPK通路并促进成牙本质分化与矿化。
  • AMPK抑制剂Compound C可逆转二甲双胍诱导的分化和矿化。

核心结论

  • 二甲双胍能以AMPK依赖方式诱导人牙髓细胞分化为成牙本质细胞并促进矿化,在再生牙髓治疗中有潜在应用价值。

研究设计与样本

  • 体外细胞实验研究,使用人牙髓细胞(DPCs),通过活/死细胞活力检测、CCK-8增殖检测、Western blot、碱性磷酸酶活性测定、von Kossa染色及逆转录PCR分析。

主要发现

  • 流式细胞术显示DPCs具有间充质干细胞特征。
  • 不同剂量二甲双胍与DPCs细胞相容,细胞活力>90%;浓度至50 μmol/L均不影响细胞增殖。
  • Western blot显示DPCs表达功能性有机阳离子转运体1,二甲双胍以剂量依赖方式显著激活AMPK通路。
  • 二甲双胍刺激碱性磷酸酶活性、增强矿化结节形成,并增加成牙本质标志物(牙本质涎磷蛋白、牙本质基质蛋白1、 runt相关转录因子2、骨钙素)表达。
  • AMPK特异性抑制剂Compound C预处理可显著逆转二甲双胍诱导的成牙本质分化和细胞矿化。

临床怎么用

  • 提示二甲双胍可能作为再生牙髓治疗的候选药物,但尚需进一步体内研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Metformin is a first-line drug for treating type 2 diabetes that regulates the differentiation of mesenchymal stem cells. Its effects on human dental pulp cells (DPCs) remain unknown. This study aimed to investigate the effects of metformin on the proliferation and differentiation of DPCs. METHODS: A live/dead viability assay kit was used to examine the effects of metformin on the cell viability of DPCs. Cell proliferation was analyzed using a cell counting kit (CCK-8; Dojindo, Tokyo, Japan). Levels of phosphorylated and unphosphorylated adenosine 5'-monophosphate-activated protein kinase (AMPK) were quantified by Western blot analysis in response to metformin and the AMPK signaling inhibitor Compound C (EMD Chemicals, San Diego, CA). The effects of Compound C on the metformin-induced odontoblast differentiation of DPCs were determined by alkaline phosphatase activity assay and von Kossa staining, and the expression of odontoblastic markers was evaluated by reverse-transcription polymerase chain reaction analysis. RESULTS: DPCs exhibited mesenchymal stem cell characteristics using flow cytometry. Different doses of metformin were shown to be cytocompatible with DPCs, yielding >90% cell viability. None of the concentrations of metformin up to 50 μmol/L affected cell proliferation. The Western blot assay showed that DPCs express functional organic cation transporter 1, a transmembrane protein that mediates the intracellular uptake of metformin. Metformin significantly activated the AMPK pathway in a dose-dependent manner. In addition, it stimulated alkaline phosphatase activity; enhanced mineralized nodule formation; and increased the expression of odontoblastic markers including dentin sialophosphoprotein, dentin matrix protein 1, runt-related transcription factor 2, and osteocalcin. Moreover, pretreatment with Compound C, a specific AMPK inhibitor, markedly reversed metformin-induced odontoblastic differentiation and cell mineralization. CONCLUSIONS: This study shows that metformin can induce DPC differentiation and mineralization in an AMPK-dependent manner and that this well-tolerated antidiabetic drug has potential in regenerative endodontics as well as in other regenerative applications.

来源:J Endod,查看原文。版权归原作者所有。

引用

  1. Qin W, Gao X, Ma T, et al. Metformin Enhances the Differentiation of Dental Pulp Cells into Odontoblasts by Activating AMPK Signaling. J Endod. 2018. PMID: 29306537. doi:10.1016/j.joen.2017.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。